DRUG INHIBITION OF KCA3.1 CHANNEL KCNN4 AS A STRATEGY TO RETARD CYST GROWTH AND DISEASE PROGRESSION IN AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE
$1,623,750FY2018Department of the ArmyDOD
Beth Israel Deaconess Medical Center, Inc.
Beth Israel Deaconess Medical Center, Inc.